Navigation Links
Cochrane Reviews in Neuromuscular Disease

ProductsCochrane Reviews in Neuromuscular Disease
Company Skyscape, Inc.
Item Cochrane Reviews in Neuromuscular Disease
  • Cochrane Reviews have become known internationally as sources of high quality, reliable health information
  • A structured format helps the reader to find his/her way around the review quickly and easily
  • Multinational editorial teams try to ensure that a review is applicable in different parts of the world
  • Cochrane Reviews are updated quarterly
Description Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source available for continually updated evidence-based medical information. Each review explores the evidence for and against the effectiveness and appropriateness of treatments (medications, surgery, education, etc) in specific circumstances.
Info Skyscape, Inc.
Customer Service: 508-460-6500
Web site:

Related medicine products :

1. Cochrane Reviews in Peripheral Vascular Diseases
2. Cochrane Reviews in Wounds
3. Cochrane Reviews in Heart
4. Cochrane Reviews in Hypertension
5. Cochrane Reviews in Epilepsy
6. Cochrane Reviews in Movement Disorders
7. Cochrane Reviews in Multiple Sclerosis
8. Cochrane Reviews in Stroke
9. Cochrane Reviews in Incontinence
10. Cochrane Reviews in Prostatic Diseases and Urologic Cancers
11. Cochrane Reviews in Back
The anti-MAG autoantibodies EIA employs the quantitative enzymatically amplified sandwich-type immunoassay technique. HIGHLY PURIFIED MAG FROM HUMAN BRAIN has been precoated onto a microtiter plate....
... Bio-Rad's CODA® Automated EIA Analyzer ... a wide range of complex microplate-based ... flexibility and efficiency to busy laboratories. ... automatically optimizes the processing of assays ...
... a diagnostic assay that quantifies the likelihood ... newly diagnosed, early stage breast cancer. In ... DX also assesses the benefit from certain ... using formalin-fixed, paraffin-embedded tumor tissue analyzes ...
... the only HER-2 assessment test approved by ... for three claims: prognosis, adriamycin-based chemotherapy selection ... PathVysion is the only FISH-based DNA probe ... insert as an appropriate test to aid ...
Medicine Products:
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone will ... close friend, or animal pass away, death lives among us. It is your perspective, ... from a family of 11 children, author T Sky understands that she may see ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. 8 virtual ... Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. Leaders from ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... The successful ... emerging pharmaceutical company. Because it is so important to this key industry segment, Regis ... in your IND Filing” on December 4th at 11am EST. , Federal law does ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the ... Matrix is a long-term resorbable surgical mesh intended to support and reinforce soft ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Cumberland Pharmaceuticals (CPIX), today announced that ... on December 3, 2015. TIME: 3:15p.m. ET ... ET LINK: --> DATE: ... --> --> ... are invited to ask the company questions in real-time - ...
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: